Joyvie Health Ltd closes first round of Pre-Seed Funding to Unlock Non-Dilutive Capital

Joyvié Health Ltd, a medtech startup pioneering a new class of patent-pending faecal management briefs, has closed its first round of pre-seed funding with the support of the FounderCatalyst platform.

Founded by Zoe Robson after a deeply personal experience caring for her late father during his battle with pancreatic cancer, Joyvié exists to restore dignity in incontinence care. Its innovation prevents faeces from touching the skin, reducing infections, preserving dignity for users, and easing the physical and emotional burden on caregivers.

The business is already de-risked by multiple Innovate UK awards and concept validation from 360 caregivers, with patents filed and prototype testing underway. This early investment will accelerate MVP finalisation and initial clinical validation, while preparing Joyvié for licensing discussions with global incumbents.

“JOYVIÉ HEALTH completed their funding round using the FounderCatalyst platform, all for a fixed fee of £1,495. A very exciting phase of growth lies ahead.”
— Max Heal, Head of Growth at FounderCatalyst

With a significant market opportunity and growing investor interest, Joyvié is now progressing towards closing the remainder of its raise and welcomes conversations with aligned investors and strategic partners.